Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes

BACKGROUND: Fibroblast growth factor 21 (FGF21) acts as a potent metabolic regulator. Serum FGF21 levels were significantly higher in obesity and type 2 diabetes mellitus (T2DM) populations. The aim of this study was to evaluate the relationship between serum FGF21 levels and metabolic syndrome (Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ruo-Yao, Hsu, Bang-Gee, Wu, Du-An, Hou, Jia-Sian, Chen, Ming-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754922/
https://www.ncbi.nlm.nih.gov/pubmed/31582974
http://dx.doi.org/10.1155/2019/5163245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754922/
https://www.ncbi.nlm.nih.gov/pubmed/31582974
http://dx.doi.org/10.1155/2019/5163245

Ejemplares similares